Does pathogen-specific IgG usually indicate past exposure rather than active infection?

Pathogen-specific IgG testing is most informative as evidence of an immune encounter, not as a stand-alone marker of current infection. This principle is particularly important when interpreting results in an older adult, in whom prior exposures accumulated over a lifetime may be common.

Clinical interpretation

• A detectable pathogen-specific IgG generally supports previous antigen exposure through natural infection or, when relevant to the assay target, vaccination. It cannot reliably date that exposure or determine whether illness has resolved.
• IgG alone does not establish active infection. Examples illustrate the principle: Babesia antibodies may persist for at least a year after recovery; EBV viral-capsid-antigen IgG usually persists lifelong; and Toxoplasma IgG indicates infection at an indeterminate time.
• Assessment of possible active disease should combine the clinical syndrome, exposure and symptom timing, and pathogen-appropriate testing. In selected infections, paired acute/convalescent samples showing seroconversion or a substantial titre rise support recent infection, although often only retrospectively.
• Serologic patterns—not an isolated IgG—can refine interpretation. For EBV, VCA IgM without EBNA IgG supports recent primary infection, while VCA IgG plus EBNA IgG without VCA IgM generally indicates past infection. Direct detection (for example, PCR/NAAT) may help when the specimen and clinical setting are appropriate, but a negative result is not universally exclusionary.

Mechanistic basis

• Persistent IgG is biologically plausible without continuing infection: long-lived plasma cells, largely residing in bone marrow, continuously secrete antigen-specific antibodies without renewed antigen exposure.
• This supports durable humoral immunity but is not a direct measurement of memory-B-cell abundance, recall function, or degree of protection.

Bottom line

• A positive pathogen-specific IgG is strong evidence of prior immune exposure and enduring antibody production, but by itself neither proves ongoing active infection nor establishes when exposure occurred.